Time From eGFR Wait-List Threshold to ESKD Shorter in Blacks
WEDNESDAY, Feb. 24, 2021 -- Black patients have a shorter time from estimated glomerular filtration rate (eGFR) levels of ≤20 mL/min/1.73 m2 to end-stage kidney disease (ESKD) onset than Whites, according to a study published online Feb. 23 in the Journal of the American Society of Nephrology.
Elaine Ku, M.D., from the University of California San Francisco, and colleagues compared racial differences in accruable wait time and kidney transplant preparation in participants of the Chronic Renal Insufficiency Cohort (CRIC), based on estimates of kidney function by creatinine (eGFRcr), cystatin C (eGRFcys), or both (eGFRcr-cys).
The researchers found that 444 CRIC participants were eligible for wait-list registration by eGFRcr, but Blacks had 32 percent shorter time than Whites in the potential time between eGFR of ≤20 mL/min/1.73 m2 and ESKD. Four hundred thirty-five participants were eligible by eGFRcys, with Blacks having 35 percent shorter potential wait time than Whites. Four hundred sixty-one participants were eligible by eGFRcr-cys, with Blacks having a 31 percent shorter potential wait time than Whites. Racial equity in accruable wait time prior to ESKD onset could be improved by registering Blacks on the wait list as early as an eGFR of 24 to 25 mL/min/1.73 m2.
"We found that use of a higher kidney function threshold to allow for earlier eligibility for waitlisting in Blacks could theoretically reduce the racial disparity in time spent in the advanced stages of chronic kidney disease," Ku said in a statement.
Several authors disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
FRIDAY, April 9, 2021 -- Patients undergoing dialysis and those with kidney transplants had increased mortality risk in 2020 compared with 2017 to 2019, according to a study...
FRIDAY, March 19, 2021 -- Use of a digital application, eKidneyCare, can reduce total medication discrepancies and the severity of clinically relevant medication discrepancies...
MONDAY, March 15, 2021 -- The 2021 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for management of blood pressure in patients with chronic kidney disease (CKD)...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.